New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis. (PubMed, J Clin Med) - Jan 26, 2025 - "With the introduction of cyclophosphamide and mycophenolate mofetil, outcomes have dramatically improved...These agents include belimumab, voclosporin, and obinutuzumab, among others...However, determining which patients would benefit the most from novel agents or combined drug regimens and whether these drugs might serve as an alternative to current remission-induction drug regimens rather than as add-on therapies remain unresolved issues. In this review, we will explore the current evidence regarding the efficacy of novel agents."
Journal • Review • Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
|
|
Augusto Vaglio; Giovanni M Rossi
|